STAT+: Pharma goes on a spending spree, snapping up biotechs in a hurry

Pharmaceutical companies are hungry to make deals, and they’re making more than they have in years.  In the past six months, there have been 33 biotech acquisitions valued at $1 billion or more, capped by AbbVie’s acquisition of Apogee Therapeutics on Monday. Pharmaceutical companies and even some large biotech companies have spent around $134 billion on these deals. They’ve blown past last year’s totals in roughly half the amount of time. Pharma companies struck 26 blockbuster M&A deals in 2025...